Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE‐AF study
Journal of the American Geriatrics Society · 2024
DOI: 10.1111/jgs.18949 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Geriatrics Society, 2024. Verfasst von Deepti S Athreya und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Science, Northeastern University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cognitive Dysfunction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Cognitive impairment is strongly associated with atrial fibrillation (AF). Rate and rhythm control are the two treatment strategies for AF and the effect of treatment strategy on risk of cognitive decline and frailty is not well established. We sought to determine how treatment strategy affects geriatric‐centered outcomes.
Methods
The Systematic Assessment of Geriatric Elements‐AF (SAGE‐AF) was a prospective, observational, cohort study. Older adults with AF were prospectively enrolled between 2016 and 2018 and followed longitudinally for 2 years. In a non‐randomized fashion, participants were grouped by rate or rhythm control treatment strategy based on clinical treatment at enrollment. Baseline characteristics were compared. Longitudinal binary mixed models were used to compare treatment strategy with respect to change in cognitive function and frailty status. Cognitive function and frailty status were assessed with the Montreal Cognitive Assessment Battery and Fried frailty phenotype tools.
Results
972 participants (mean age = 75, SD = 6.8; 49% female, 87% non‐Hispanic white) completed baseline examination and 2‐year follow‐up. 408 (42%) were treated with rate control and 564 (58%) with rhythm control. The patient characteristics of the two groups were different at baseline. Participants in the rate control group were older, more likely to have persistent AF, prior stroke, be treated with warfarin and have baseline cognitive impairment. After adjusting for baseline differences, participants treated with rate control were 1.5 times more likely to be cognitively impaired over 2 years (adjusted OR: 1.47, 95% CI:1.12, 1.98) and had a greater decline in cognitive function (adjusted estimate: −0.59 (0.23), p < 0.01) in comparison to rhythm control. Frailty did not vary between the treatment strategies.
Conclusions
Among those who had 2‐year follow‐up in non‐randomized observational cohort, the decision to rate control AF in older adults was associated with increased odds of decline in cognitive function but not frailty.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Science, Northeastern University, Boston, Massachusetts, USA.
- Department of Pharmacy and Health System Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
- Meyers Primary Care Institute and Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
- Evans Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
- Division of Cardiology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
- Department of Medicine, Mercer University School of Medicine, Mercer, Georgia, USA.
ORCID-Profile: Benita A Bamgbade, Robert H Helm
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Athreya, D. S., Saczynski, J. S., Gurwitz, J. H., Monahan, K. M., Bamgbade, B. A., Paul, T. J., Sogade, F., Lessard, D. M., McManus, D. D., & Helm, R. H. (2024). Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE‐AF study. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.18949
Vancouver
Athreya DS, Saczynski JS, Gurwitz JH, Monahan KM, Bamgbade BA, Paul TJ, et al. Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE‐AF study. Journal of the American Geriatrics Society. 2024. doi:10.1111/jgs.18949
BibTeX
@article{Athreya2024,
author = {Athreya, Deepti S and Saczynski, Jane S and Gurwitz, Jerry H and Monahan, Kevin M and Bamgbade, Benita A and Paul, Tenes J and Sogade, Felix and Lessard, Darleen M and McManus, David D and Helm, Robert H},
title = {Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE‐AF study},
journal = {Journal of the American Geriatrics Society},
year = {2024},
doi = {10.1111/jgs.18949}
}
EUVIMED